Latest Food and Drug Administration Stories
- Amended protocol includes enhanced blood pressure monitoring to ensure optimal patient management - FRAMINGHAM, Mass., and SYDNEY, June 17, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval to an IDE...
Agreement is the first to emerge under exclusive partnership between Imprimis Pharmaceuticals and Professional Compounding Centers of America (PCCA); acquisition allows Imprimis to begin to develop certain innovations created by Ohio-based compounding pharmacy. SAN DIEGO, Calif., June 17, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) today announced it has completed the acquisition of intellectual property (IP) rights related to certain proprietary innovations...
Will Techmeier of the Cochran Firm Wisconsin LLP says the firm has added new content to its website to provide concerned consumers and their families with general information about the Yaz and Yasmin birth control pills. Milwaukee, WI (PRWEB) June 15, 2013 Will Techmeier, the senior partner of the Cochran Firm Wisconsin LLP, said his law firm is alarmed by a recent news report on the “suspected” connection between the Yaz and Yasmin birth control pills and the deaths of 23 Canadian...
The Firm is currently investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious internal bleeding, a potentially life-threatening Pradaxa side effect. New York, New York (PRWEB) June 15, 2013 Hundreds of Pradaxa lawsuit claims continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, the Court held a Status Conference on June 10th, at...
Alliance helps pharmaceutical companies maintain high quality control standards amidst tough regulations. West Chester, PA (PRWEB) June 14, 2013 Smart Consulting Group and The Catalyst Group have formed an alliance to provide consultation and staff augmentation services that helps the pharmaceutical industry maintain the highest standards in quality compliance. The Smart Consulting Group / Catalyst Group alliance is now helping even the largest companies to maintain good manufacturing...
Company builds on new initiatives in clinical guidelines and regulatory affairs Santa Monica, CA (PRWEB) June 14, 2013 Doctor Evidence, LLC continued its multiple-year trend of sustained growth with sales bookings increased over 163% year-over-year from 2011 to 2012. Revenue growth represented an increase of 100% in the same period. Doctor Evidence’s 2012 success can be attributed both to the expansion of existing projects as well as the start of new initiatives with a varied list of...
Alert: Diabetes Drug Actos Has Allegedly Been Linked to Serious Health Problems, Including Bladder Cancer DALLAS (PRWEB) June 14, 2013 National plaintiffs’ law firm Baron and Budd is now handling lawsuits regarding the alleged adverse side effects of the diabetes drug Actos. Actos, also known as pioglitazone, has been prescribed since 1999 to help treat type 2 diabetes. The drug was marketed to help people control blood sugar levels with a minimum of side effects, making it a...
The Firm is investigating GranuFlo lawsuits on behalf of dialysis patients who allegedly experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects related to the GranuFlo recall for GranuFlo and NaturaLyte Dialysis Drugs. New York, New York (PRWEB) June 14, 2013 GranuFlo lawsuit claims filed in the wake of last year’s recall for GranuFlo and NaturaLyte dialysis drugs continue to mount in the federal multidistrict litigation now underway in U.S....
NEW YORK, June 14, 2013 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTC Pink: SVFC) announced today that on May 14, 2013 through June 2, 2013, its cellular laboratory facility underwent a thorough inspection by the FDA. The observations from the FDA inspection were provided to the company in the Form 483. The Company will respond to those observations in a timely manner. IntelliCell will take the necessary actions to address the relevant FDA observations....
The firm is currently evaluating Byetta, Victoza and Januvia lawsuits for those who have suffered from the allegedly serious side effects of the drugs. (PRWEB) June 13, 2013 Following the American Diabetes Association’s call for a safety review of diabetes drugs because of potential pancreatic cancer links, the makers of Byetta, Januvia and Victoza announced June 12 they will voluntarily participate in the new evaluation of clinical data, according to Reuters.* The Rottenstein Law Group...
Latest Food and Drug Administration Reference Libraries
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
